The Panomles Approach in Neurodegenerative Disorders

被引:3
|
作者
Szatmari, Balazs [1 ]
Balicza, Peter [2 ]
Nemeth, Gyorgy [1 ]
Molnar, Maria Judit [2 ]
机构
[1] Gedeon Richter Plc, Med Div, Budapest, Hungary
[2] Semmelweis Univ, Inst Genom Med & Rare Dis Orders, Budapest, Hungary
关键词
Omics; classification; neurodegenerative disorders; multidisciplinary approach; genetics; imaging; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; TREM2; VARIANTS; PET; PATHOLOGY; NEUROINFLAMMATION; SAFETY;
D O I
10.2174/0929867324666170705120038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The molecular genetic technologies revolutionized the diagnostics of many disorders. Thanks to the new molecular techniques and the rapid improvement of the information technologies the number of mendelien inherited disorders has increased rapidly in the last five years. The omics era brought radical changes in the understanding of complex disorders and the underlying pathomechanisms. However, in most complex disorders the genome wide association studies could not clarify the genetic background even for disorders where a very strong heritability had been observed. Objective: In this paper the changing concept of the neurodegenerative disorders is discussed. The traditional classification of these disorders was purely based on clinical symptoms and morphological signs in the last century. Identifying the signature lesions of various neurodegenerative disorders may reveal a common pathological pathway in these disorders, New neuroimaging methods provided additional tools to assess pathological pathways in vivo already in the early stages of the diseases, Visualizing in vivo amyloid deposits and neuroinflammation improved our understanding of their role in various neurodegenerative disorders. Genetics may be the most precise way to identify the background of these disorders, However, there is only limited number of cases where true association can he proved between the disorder and the genetic mutations. Most of the neurodegenerative disorders seem to be multifactorial and cannot be traced back to one single cause. Conclusion: In conclusion, shifting from a classification based on symptomatology only to a modern multidisciplinary approach, based on the constantly evolving panomics findings, would improve our understanding of neurodegenerative diseases and could be the basis of novel therapeutic research.
引用
收藏
页码:1712 / 1720
页数:9
相关论文
共 50 条
  • [31] Therapeutic strategies for targeting neurodegenerative protein misfolding disorders
    Scannevin, Robert H.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2018, 44 : 66 - 74
  • [32] Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
    Schiavone, Stefania
    Trabace, Luigia
    MOLECULES, 2018, 23 (02):
  • [33] The presymptomatic stage of neurodegenerative disorders
    Klein, C.
    Hagenah, J.
    Landwehrmeyer, B.
    Muente, T.
    Klockgether, T.
    NERVENARZT, 2011, 82 (08): : 994 - +
  • [34] Genetics of prevalent neurodegenerative disorders
    Llado, Albert
    Gaig, Carles
    Molinuevo, Jose L.
    MEDICINA CLINICA, 2006, 126 (17): : 662 - 670
  • [35] Weight loss in neurodegenerative disorders
    Aziz, N. Ahmad
    van der Marck, Marjolein A.
    Pijl, Hanno
    Rikkert, Marcel G. M. Olde
    Bloem, Bastiaan R.
    Roos, Raymund A. C.
    JOURNAL OF NEUROLOGY, 2008, 255 (12) : 1872 - 1880
  • [36] DNA Methylation in Neurodegenerative Disorders
    Xu, Zihui
    Xuekun Li
    CURRENT GERIATRICS REPORTS, 2012, 1 (04) : 199 - 205
  • [37] Mitochondrial dysfunction in neurodegenerative disorders
    Klemmensen, Madelyn M.
    Borrowman, Seth H.
    Pearce, Colin
    Pyles, Benjamin
    Chandra, Bharatendu
    NEUROTHERAPEUTICS, 2024, 21 (01)
  • [38] Visual Hallucinations in Neurodegenerative Disorders
    Papapetropoulos, Spyridon
    Scanlon, Blake K.
    NEUROPSYCHIATRIC DISORDERS, 2010, : 51 - 63
  • [39] Gene networks in neurodegenerative disorders
    Recabarren, Daniela
    Alarcon, Marcelo
    LIFE SCIENCES, 2017, 183 : 83 - 97
  • [40] Antioxidants as treatment for neurodegenerative disorders
    Moosmann, B
    Behl, C
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (10) : 1407 - 1435